Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare, VA/DoD Rx Joint Procurement Study Requested By Sen. Specter

Executive Summary

Senate Veterans' Affairs Committee Ranking Member Specter (R-Penn.) is requesting an assessment of linking Medicare drug purchases with the Departments of Defense and Veterans Affairs.

You may also be interested in...

Florida Medicaid Formulary Exclusions Are Not Final, Bristol Tells Investors

The exclusion of Pravachol and Plavix from Florida's initial Medicaid formulary should not be considered final, Bristol-Myers Squibb Worldwide Group Medicines President Richard Lane told an investor conference call July 25.

Medicare Rx Will Move Towards FSS Pricing Model - Sen. Rockefeller

A Medicare prescription drug benefit will eventually employ a Federal Supply Schedule-style pricing model, Sen. Rockefeller (D-W.Va.) suggested during a June 12 press conference.

DoD/VA Allegra Price Is One-Third Of AWP; Joint Procurement Expands

The Departments of Defense and Veterans Affairs have awarded a joint national procurement contract to Aventis' Allegra (fexofenadine) for approximately one-third the average wholesale price.

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts